SCHEMBL515456

SCHEMBL515456

[NH][N+](=O)[O-]

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Water SCHEMBL10524782 0.75 MEN1 (0.67)
SCHEMBL29903444 0.75
SCHEMBL136652 0.72
SCHEMBL31709992 0.72 MEN1 (0.86)
SCHEMBL9093617 0.72 MEN1 (0.86)
SCHEMBL14916717 0.72 MEN1 (0.86)
SCHEMBL30925695 0.71
SCHEMBL25220265 0.67 MEN1 (0.75)
SCHEMBL3899631 0.67 MEN1 (0.75)
SCHEMBL344814 0.67 MEN1 (0.75)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 376 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11680071-B2 Compound and organic light emitting device comprising the same LG CHEM, LTD. (KR) 2023-06-20 US claimed
CN-113453763-A Ether compound and harmful arthropod control composition containing same 住友化学株式会社 2021-09-28 CN claimed
WO-2020034601-A1 COMPOUND AND PREPARATION AND APPLICATION THEREOF 中国工程物理研究院化工材料研究所 2020-02-20 WO claimed
CN-107454842-A New calcium regulator 莫尔瑟瑞克斯股份有限公司 2017-12-08 CN claimed
CN-106572988-A INOS-inhibitory compositions and their use as breast cancer therapeutics 卫理公会医院 2017-04-19 CN claimed
US-20150183787-A1 PROPELLANE-BASED COMPOUNDS AND THE USE THEREOF PURDUE PHARMA L.P. 2015-07-02 US claimed
WO-2013120896-A1 COMPOUND FOR USE IN THE PREVENTION AND/OR TREATMENT OF A NEUROGENERATIVE DISEASE OR A DISEASE INVOLVING AN ACTIVATION OF PHOSPHODIESTERASE-4 (PDE4) HARMONIC PHARMA (FR) 2013-08-22 WO claimed
EP-2626073-A1 Compound for use in the prevention and/or treatment of a neurogenerative disease or a disease involving an activation of phosphodiesterase-4 (PDE4) Harmonic Pharma (FR) 2013-08-14 EP claimed
WO-2013060881-A1 PYRIDOPYRIMIDINES AND THEIR THERAPEUTIC USE VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS, WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG (NL) 2013-05-02 WO claimed
US-8284374-B2 Liquid crystal display device LG DISPLAY CO., LTD. (KR) 2012-10-09 US claimed
EP-0279350-A2 Fused azepinone and azocinone derivatives , process for their preparation, agents containing them and their use, as well as their intermediates during their production HOECHST AKTIENGESELLSCHAFT (DE) 1988-08-24 EP claimed
US-4640924-A ANTIDEPRESSANTS, ANTICOAGULANTS, AND ANTIDIABETIC AGENTS JOHN WYETH & BROTHER LIMITED (GB) 1987-02-03 US claimed
US-4526891-A Analgesics HOECHST ROUSSEL PHARMACEUTICALS INC. (US) 1985-07-02 US claimed
US-4377580-A ANTIALLERGENIC AGENTS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1983-03-22 US claimed
EP-0015523-B1 INDOLE DERIVATIVES, THEIR PREPARATION AND THEIR USE FOR MEDICAMENTS Dr. Karl Thomae GmbH (DE) 1982-10-13 EP claimed
US-4211791-A Indanediones BEECHAM GROUP LIMITED (GB) 1980-07-08 US claimed
US-4207335-A ANTIALLERGENS BEECHAM GROUP LIMITED (GB) 1980-06-10 US claimed
US-4200577-A ANTIALLERGENS, ANTIHISTAMINES BEECHAM GROUP LIMITED (GB) 1980-04-29 US claimed
US-4136192-A ANTIALLERGENS BEECHAM GROUP LIMITED (GB) 1979-01-23 US claimed
US-4071350-A THIOCARBAMATES STAUFFER CHEMICAL COMPANY (US) 1978-01-31 US claimed